about
Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.Cytotoxic Conjugates of Fibroblast Growth Factor 2 (FGF2) with Monomethyl Auristatin E for Effective Killing of Cells Expressing FGF Receptors.Stimuli-responsive, biocompatible hydrogel derived from glycogen and poly(N-isopropylacrylamide) for colon targeted delivery of ornidazole and 5-amino salicylic acid
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug Delivery Research: The Invention Cycle.
@en
Drug Delivery Research: The Invention Cycle.
@nl
type
label
Drug Delivery Research: The Invention Cycle.
@en
Drug Delivery Research: The Invention Cycle.
@nl
prefLabel
Drug Delivery Research: The Invention Cycle.
@en
Drug Delivery Research: The Invention Cycle.
@nl
P2860
P1476
Drug Delivery Research: The Invention Cycle.
@en
P2093
Kinam Park
P2860
P304
P356
10.1021/ACS.MOLPHARMACEUT.6B00015
P407
P577
2016-03-10T00:00:00Z